Expansion Momentum Elite DNA is operating nearly 40 locations across Florida, Virginia, and Alabama after 2026 openings and acquisitions, signaling a multi-state platform ready for scale. This expansion creates opportunities to partner with payers, health systems, school districts, and employer coalitions in new markets and to extend telehealth and integrated services regionally.

Integrated Care The interdisciplinary model combines psychiatric evaluation, therapy, medication management, care coordination, TMS, ABA, OT, and SLP under one roof, enabling cross-sell and value-based care partnerships with insurers, hospitals, and population health programs.

Neurostimulation A strategic NeuroStar partnership with Neuronetics and a broad TMS offering position Elite DNA as a preferred channel for neuromodulation therapies, opening conversations with device manufacturers, hospital networks, and rehab providers to expand access.

Pediatric Specialties Services for children and adolescents, trauma therapy, LGBTQIA+ mental health, and ABA create opportunities to collaborate with schools, pediatric clinics, community organizations, and government programs for school-based and early-intervention mental health initiatives.

Growth Strategy With recent acquisitions such as Dbmclinic and multi-state expansion, Elite DNA is primed for partnerships with payers and provider networks; potential to streamline credentialing, billing, and care coordination across states, and to explore M&A opportunities to extend reach.